Patents by Inventor Yoshiki Nishizawa

Yoshiki Nishizawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016832
    Abstract: A dialysate for hemodialysis contains electrolyzed hydrogen water, has a dissolved hydrogen concentration of 100 ppb to 200 ppb, and has an activity of reducing a feeling of fatigue.
    Type: Application
    Filed: July 13, 2023
    Publication date: January 18, 2024
    Inventors: Masaaki NAKAYAMA, Yasuyoshi WATANABE, Yoshiki NISHIZAWA, Shigeru KABAYAMA
  • Patent number: 9642938
    Abstract: In order to provide (i) a medical composition that has a strong angiogenic effect, has low invasiveness to a body of a patient, and is easy to administer to a living subject and (ii) a medical kit using a medical composition, the medical composition includes: a carrier in a particle form, the carrier having (a) a support made from a bioabsorbable polymer and (b) a surface layer made from hydroxyapatite and provided on the support; and cells provided on a surface of the carrier.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: May 9, 2017
    Assignees: OSAKA CITY UNIVERSITY, JAPAN HEALTH SCIENCES FOUNDATION
    Inventors: Shinya Fukumoto, Hidenori Koyama, Yoshiki Nishizawa, Tsutomu Furuzono, Masahiro Okada
  • Publication number: 20160213296
    Abstract: The system enables a subject himself to decide on a proper remedial measure, without obtaining particular instruction directly from a medical professional, by providing an advice corresponding to a decision criteria of a plurality of classifications (3x4=12) stored in the storage unit, based on a plurality of autonomic nerve function age ranks and a plurality of autonomic nerve function age ranks A screening system for fatigue and stress has a storage unit which, during screening for fatigue and stress, stores master data composed of reference values for each age, a decision unit which decides by comparing a measurement data obtained by electrocardiogram and pulse wave measurement of the subject with the reference value, and outputs a result of decision classified into the plurality of classifications, and a computing unit which receives the decision results, and calculates autonomic nerve function age ranks, wherein the decision means has an autonomic nerve decision unit which decides autonomic nerve strengt
    Type: Application
    Filed: May 28, 2014
    Publication date: July 28, 2016
    Inventors: Osamu Kikuchi, Takayuki Matsubara, Masutoyo Miyamoto, Seiki Tajima, Junichi Koizumi, Yosuke Kataoka, Hirohiko Kuratsune, Yasuyoshi Watanabe, Yoshiki Nishizawa
  • Publication number: 20110104292
    Abstract: In order to provide (i) a medical composition that has a strong angiogenic effect, has low invasiveness to a body of a patient, and is easy to administer to a living subject and (ii) a medical kit using a medical composition, the medical composition includes: a carrier in a particle form, the carrier having (a) a support made from a bioabsorbable polymer and (b) a surface layer made from hydroxyapatite and provided on the support; and cells provided on a surface of the carrier.
    Type: Application
    Filed: June 26, 2009
    Publication date: May 5, 2011
    Inventors: Shinya Fukumoto, Hidenori Koyama, Yoshiki Nishizawa, Tsutomu Furuzono, Masahiro Okada
  • Publication number: 20090318814
    Abstract: The present invention is a method and an apparatus for examination/diagnosis of lifestyle related disease, wherein the test sample from a human or other animal subject is irradiated with light having a wavelength region of a region of 400 nm-2,500 nm or a part of the region, of which the reflection light, the transmission light, or the transmission reflection light is then detected to give spectroscopic data of absorbance, and afterward a previously prepared analysis model is used to execute an analysis of the absorbance at the whole or specific wavelength used for the measurement.
    Type: Application
    Filed: December 1, 2006
    Publication date: December 24, 2009
    Inventors: Hirohiko Kuratsune, Akikazu Sakudo, Kazuyoshi Ikuta, Yasuyoshi Watanabe, Yoshiki Nishizawa, Yukiyoshi Hirase, Seiki Tajima, Yoshikazu Suganuma
  • Publication number: 20080182893
    Abstract: Disclosed is an anti-atherogenic composition or an atherosclerosis progression inhibitory composition which can be used effectively for preventing or ameliorating atherosclerosis. The anti-atherogenic composition or atherosclerosis progression inhibitory composition comprises an enzyme-treated isoquercitrin as the active ingredient.
    Type: Application
    Filed: March 6, 2006
    Publication date: July 31, 2008
    Applicant: SAN-EI GEN F.F.I., INC.
    Inventors: Yoshiki Nishizawa, Hidenori Koyama, Koka Motoyama, Masamitsu Moriwaki, Kazuhiro Emura, Mikio Nakamura